Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):201–206. doi: 10.1016/j.ijrobp.2009.01.046

Table 2.

Outcomes by site of recurrence and RT dose in abdominal stage II and III patients: each patient evaluated for both sites of potential recurrence.

Flank Beyond - Flank


RT dose # Evaluated # Events (%) # Evaluated # Events(%)
No RT 105 13(12.4) 292 18(6.2)
10 Gy 231 7(3.0) 120 3(2.5)
20 Gy 114 0(0.0) 38 1(2.6)
Total 450 20(4.4) 450 22(4.9)